Dec 31, 2022

Arcturus Therapeutics Q4 2022 Earnings Report

Total Revenue
$160M
Previous year: $5.79M
+2666.5%
EPS
$4.33
Previous year: -$1.47
-394.6%
Gross Profit
$160M
Previous year: $5.79M
+2666.5%
Cash and Equivalents
$392M
Previous year: $370M
+5.8%
Free Cash Flow
$156M
Previous year: -$43.6M
-458.7%
Total Assets
$450M
Previous year: $393M
+14.7%

Arcturus Therapeutics

Arcturus Therapeutics